RecruitingPhase 3NCT06259097
Different Medications to Induce Labor
Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial
Sponsor
Icahn School of Medicine at Mount Sinai
Enrollment
300 participants
Start Date
Jul 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria1
- \- Pregnant patient presenting to labor \& delivery for induction of labor with a BMI \> = 30
Exclusion Criteria1
- \- Pregnant patient presenting to labor \& delivery for induction of labor with BMI \< 30
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGMisoprostol
25 mcg vaginally every 6 hours
DRUGPitocin
3-6 mL intravenously every hour
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06259097
Related Trials
Intra-abdominal Pressure, Abdominal Circumference, and Spinal Block Level in Cesarean Section
NCT074063731 location
Vitamin D Dynamics in Women
NCT027052871 location
Comparison of Bone Mineral Density in the Third Trimester Between Women in Singleton and Twin Pregnancies Using Questionnaires and REMS Densitometric Examination
NCT075085531 location
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
NCT072078769 locations
Preoperative Shock Indexes and Post-Spinal Hypotension in Cesarean Surgery
NCT075005191 location